Baidu
map

Cancer Discovery:鉴定出增加胰腺癌的风险基因

2012-01-06 MedSci原创 MedSci原创

根据美国癌症研究协会最新期刊Cancer Discovery上发表的数据,ATM基因上的突变可增加胰腺癌的遗传风险。 胰腺癌是一种最病态的癌症,患有这种疾病的人能存活5年的人不到5%。大约10%的患者来自具多例胰腺癌的家庭。 "有重要理由相信,这种群集是由于遗传,但就这一点,我们没能够找到解释大多数这种家庭胰腺癌群集的致病基因",主要作者Alison Klein博士说,她是约翰霍普金斯Sidn

根据美国癌症研究协会最新期刊Cancer Discovery上发表的数据,ATM基因上的突变可增加胰腺癌的遗传风险。

胰腺癌是一种最病态的癌症,患有这种疾病的人能存活5年的人不到5%。大约10%的患者来自具多例胰腺癌的家庭。

"有重要理由相信,这种群集是由于遗传,但就这一点,我们没能够找到解释大多数这种家庭胰腺癌群集的致病基因",主要作者Alison Klein博士说,她是约翰霍普金斯Sidney Kimmel综合癌症中心肿瘤学副教授、国家家族性胰腺肿瘤登记处主任。

Klein和同事们使用包括全基因组和整个外显子组分析的新一代测序法,在具有家族性胰腺癌的两个家族中鉴定出ATM基因的突变。

当在一大族患者中检查到这些初步结果时,166个患胰腺癌受试者中有4个存在ATM基因突变,但是在190个配偶控制组中不存在。

Klein说,对ATM基因存在的认识可能会导致形成更好的胰腺癌筛查,其中胰腺癌第四个最常见的癌症相关性死亡的原因。然而,目前还没有建议的筛查测试。

许多医用用内窥镜检查法作为胰腺癌的筛查工具,但是研究人员仍在临床试验中评估这一技术。(生物谷bioon.com)

ATM Mutations in Patients with Hereditary Pancreatic Cancer

Nicholas J. Roberts, Yuchen Jiao, Jun Yu, Levy Kopelovich, Gloria M. Petersen,Melissa L. Bondy, Steven Gallinger, Ann G. Schwartz, Sapna Syngal, Michele L. Cote,Jennifer Axilbund, Richard Schulick, Syed Z. Ali, James R. Eshleman,Victor E. Velculescu, Michael Goggins, Bert Vogelstein, Nickolas Papadopoulos,Ralph H. Hruban, Kenneth W. Kinzler, and Alison P. Klein

Abstract Pancreatic cancers are the fourth most-common cause of cancer-related deaths in the Western world, with >200,000 cases reported in 2010. Although up to 10% of these cases occur in familial patterns, the hereditary basis for predisposition in the vast majority of affected families is unknown. We used next-generation sequencing, including whole-genome and whole-exome analyses, and identified heterozygous, constitutional, ataxia telangiectasia mutated (ATM) gene mutations in 2 kindreds with familial pancreatic cancer. Mutations segregated with disease in both kindreds and tumor analysis demonstrated LOH of the wild-type allele. By using sequence analysis of an additional 166 familial pancreatic cancer probands, we identified 4 additional patients with deleterious mutations in the ATM gene, whereas we identified no deleterious mutations in 190 spouse controls (P = 0.046). When we considered only the mostly severely affected families with 3 or more pancreatic cancer cases, 4 deleterious mutations were found in 87 families (P = 0.009). Our results indicate that inherited ATM mutations play an important role in familial pancreatic cancer predisposition. Significance: The genes responsible for the majority of cases of familial pancreatic ductal adenocarcinoma are unknown. We here identify ATM as a predisposition gene for pancreatic ductal adenocarcinoma. Our results have important implications for the management of patients in affected families and illustrate the power of genome-wide sequencing to identify the basis of familial cancer syndromes. Cancer Discovery; 2(1): OF1-OF6. ?2011 AACR.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2011768, encodeId=6b0d2011e6803, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Jul 27 22:06:00 CST 2012, time=2012-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1783671, encodeId=c8e91e8367190, content=<a href='/topic/show?id=d195513038' target=_blank style='color:#2F92EE;'>#cover#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5130, encryptionId=d195513038, topicName=cover)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Tue Mar 20 12:06:00 CST 2012, time=2012-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442668, encodeId=089c14426686d, content=<a href='/topic/show?id=75a51008e363' target=_blank style='color:#2F92EE;'>#风险基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100873, encryptionId=75a51008e363, topicName=风险基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cf64946767, createdName=12498cbcm01(暂无昵称), createdTime=Sun Jan 08 14:06:00 CST 2012, time=2012-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587736, encodeId=8f58158e7368f, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10067, encryptionId=cb1e1006ebd, topicName=ISC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=173417575755, createdName=yankaienglish, createdTime=Sun Jan 08 14:06:00 CST 2012, time=2012-01-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2011768, encodeId=6b0d2011e6803, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Jul 27 22:06:00 CST 2012, time=2012-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1783671, encodeId=c8e91e8367190, content=<a href='/topic/show?id=d195513038' target=_blank style='color:#2F92EE;'>#cover#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5130, encryptionId=d195513038, topicName=cover)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Tue Mar 20 12:06:00 CST 2012, time=2012-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442668, encodeId=089c14426686d, content=<a href='/topic/show?id=75a51008e363' target=_blank style='color:#2F92EE;'>#风险基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100873, encryptionId=75a51008e363, topicName=风险基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cf64946767, createdName=12498cbcm01(暂无昵称), createdTime=Sun Jan 08 14:06:00 CST 2012, time=2012-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587736, encodeId=8f58158e7368f, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10067, encryptionId=cb1e1006ebd, topicName=ISC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=173417575755, createdName=yankaienglish, createdTime=Sun Jan 08 14:06:00 CST 2012, time=2012-01-08, status=1, ipAttribution=)]
    2012-03-20 yahu
  3. [GetPortalCommentsPageByObjectIdResponse(id=2011768, encodeId=6b0d2011e6803, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Jul 27 22:06:00 CST 2012, time=2012-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1783671, encodeId=c8e91e8367190, content=<a href='/topic/show?id=d195513038' target=_blank style='color:#2F92EE;'>#cover#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5130, encryptionId=d195513038, topicName=cover)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Tue Mar 20 12:06:00 CST 2012, time=2012-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442668, encodeId=089c14426686d, content=<a href='/topic/show?id=75a51008e363' target=_blank style='color:#2F92EE;'>#风险基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100873, encryptionId=75a51008e363, topicName=风险基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cf64946767, createdName=12498cbcm01(暂无昵称), createdTime=Sun Jan 08 14:06:00 CST 2012, time=2012-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587736, encodeId=8f58158e7368f, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10067, encryptionId=cb1e1006ebd, topicName=ISC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=173417575755, createdName=yankaienglish, createdTime=Sun Jan 08 14:06:00 CST 2012, time=2012-01-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2011768, encodeId=6b0d2011e6803, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Jul 27 22:06:00 CST 2012, time=2012-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1783671, encodeId=c8e91e8367190, content=<a href='/topic/show?id=d195513038' target=_blank style='color:#2F92EE;'>#cover#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5130, encryptionId=d195513038, topicName=cover)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Tue Mar 20 12:06:00 CST 2012, time=2012-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442668, encodeId=089c14426686d, content=<a href='/topic/show?id=75a51008e363' target=_blank style='color:#2F92EE;'>#风险基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100873, encryptionId=75a51008e363, topicName=风险基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cf64946767, createdName=12498cbcm01(暂无昵称), createdTime=Sun Jan 08 14:06:00 CST 2012, time=2012-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587736, encodeId=8f58158e7368f, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10067, encryptionId=cb1e1006ebd, topicName=ISC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=173417575755, createdName=yankaienglish, createdTime=Sun Jan 08 14:06:00 CST 2012, time=2012-01-08, status=1, ipAttribution=)]
    2012-01-08 yankaienglish

相关资讯

新发糖尿病警惕胰腺癌的发生

作者:上海交通大学医学院瑞金医院消化科 袁耀宗 来源:中国医学论坛报        糖尿病与胰腺癌的关系一直备受关注。最近,美国M. D.安德森癌症中心学者对3个大型病例对照研究汇总分析,发现长期患有糖尿病是独立于肥胖和吸烟之外的胰腺癌危险因素。该研究纳入2192例胰腺癌患者和5113例对照,多因素分析显示,糖尿病与胰腺癌

胰腺癌普通外科临床路径(2011年版)

胰腺癌临床路径   (2011年版)      一、胰腺癌临床路径标准住院流程   (一)适用对象。   第一诊断为胰腺癌(ICD-10:C25.0)   行胰头癌根治术或胰体尾癌根治术(ICD-9-CM-3:52.5-52.7)。   (二)诊断依据。   根据《临床诊疗指南-外科学分册》(人民卫生出版社,2006年,第1版)、《黄家驷外科学》(人民卫生出版社,2008年,第7

晚期胰腺癌一线治疗进展

马冬副教授  广东省人民医院肿瘤中心消化肿瘤科主任,副主任医师。兼任CSCO胃肠胰神经内分泌肿瘤专家委员会委员、广东省抗癌协会化疗专业委员会副主任委员等,致力于消化系统恶性肿瘤多学科综合治疗的基础研究和临床研究。   目前,胰腺癌仍是难治性肿瘤之一,系统治疗的疗效并不令人满意。在今年的美国临床肿瘤学会(ASCO)年会上,有关晚期胰腺癌一线治疗的研究亮点主要是6 项随机对照临床

胰腺癌诊治的瓶颈· 探索· 思考

 2011年8月13日至14日,以“加强多学科合作、推荐胰腺癌规范化诊治”为主题的第二届上海胰腺癌论坛暨2011年中国抗癌协会临床肿瘤学协作专业委员会(CSCO)胰腺癌论坛在上海召开。会议由CSCO、中华医学会上海分会肿瘤专科委员会和上海市抗癌学会共同举办,来自中国、美国、日本、韩国的胰腺癌专家共聚一堂,展示了基础研究的最新进展,分享了外科、化疗、放疗、中医等学科的胰腺癌诊治观点。   胰腺癌被

胰腺癌诊疗规范(2011年版)

 10月14日,卫生部网站发布信息,为规范我国胰腺癌临床诊疗行为,进一步提高我国医疗机构胰腺癌诊疗水平,保障医疗质量和医疗安全,提高我国胰腺癌患者生存率,降低病死率,卫生部部组织专家制定了《胰腺癌诊疗规范(2011年版)》。   请从卫生部网站下载《胰腺癌诊疗规范(2011年版)》。   附件:胰腺癌诊疗规范.doc 或本地下载:doc13075.doc

2011年NCCN胰腺癌临床实践指南(可下载)

2011年NCCN胰腺癌临床实践指南.pdf

Baidu
map
Baidu
map
Baidu
map